Rauschecker J P, Egert U, Kossel A
Max-Planck-Institut für Biologische Kybernetik, Tübingen, F.R.G.
Int J Dev Neurosci. 1990;8(4):425-35. doi: 10.1016/0736-5748(90)90075-d.
The existence of Hebb synapses in the visual cortex of young kittens has long been postulated. A mechanism for the correlation of activity in simultaneously active pre- and postsynaptic neurons could be provided by the properties of the N-methyl-D-aspartate (NMDA) receptor and its associated Ca2+ channel, which opens in a transmitter- and voltage-dependent manner. We have studied the effects on cortical plasticity of blocking NMDA receptors in different ways with competitive and non-competitive NMDA antagonists. In our first approach, the non-competitive NMDA antagonist ketamine, a short-acting dissociative anaesthetic, was injected systemically after each of a series of brief monocular exposures. This procedure prevented the development of an ocular dominance shift towards the experienced eye in the visual cortex. Other short-acting anaesthetics, such as xylazine or methohexital, while providing the same depth of anaesthesia, did not have the same effect on ocular dominance plasticity. We conclude, therefore, that ketamine quite specifically interferes with synaptic consolidation in the visual cortex. In order to establish a role of NMDA receptors for cortical plasticity directly in the visual cortex, we performed another series of experiments: 2-amino-5-phosphono-valerate (APV), a competitive NMDA antagonist, was infused intracortically by means of implanted osmotic minipumps in kittens, which were monocularly deprived for 1-2 weeks. Within a radius of 4-5 mm, the expected ocular dominance shift was prevented or reduced. In addition, however, physiologically determined cell density and responsiveness to visual stimuli were grossly abnormal around the infusion site, and histological cell density was also reduced. Similar effects were found when MK801 (a non-competitive NMDA antagonist) was used in the same type of experiment. The outcome of both experimental approaches makes it very likely that NMDA antagonists somehow interfere with cortical plasticity. Their mode of action, however, remains ambiguous. Although it is quite possible that blocking of the NMDA channel prevents the Hebbian correlative process necessary for synaptic consolidation, more complex effects, such as an interference with a neurotrophic action normally exerted via the NMDA receptor, may have to be taken into account as well.
长期以来,人们一直假定幼猫视觉皮层中存在赫布突触。N-甲基-D-天冬氨酸(NMDA)受体及其相关的Ca2+通道的特性可以为同时活跃的突触前和突触后神经元的活动相关性提供一种机制,该通道以递质和电压依赖的方式开放。我们研究了用竞争性和非竞争性NMDA拮抗剂以不同方式阻断NMDA受体对皮层可塑性的影响。在我们的第一种方法中,在一系列短暂的单眼暴露之后,全身注射非竞争性NMDA拮抗剂氯胺酮,一种短效解离麻醉剂。这一程序阻止了视觉皮层中眼优势向经验丰富的眼睛转移的发展。其他短效麻醉剂,如赛拉嗪或美索比妥,虽然提供相同的麻醉深度,但对眼优势可塑性没有相同的影响。因此,我们得出结论,氯胺酮非常特异性地干扰视觉皮层中的突触巩固。为了直接在视觉皮层中确立NMDA受体对皮层可塑性的作用,我们进行了另一系列实验:通过植入的渗透微型泵向单眼剥夺1 - 2周的幼猫皮层内注入竞争性NMDA拮抗剂2-氨基-5-磷酸戊酸(APV)。在4 - 5毫米的半径范围内,预期的眼优势转移被阻止或减少。然而,除此之外,在注入部位周围,生理测定的细胞密度和对视觉刺激的反应性严重异常,并且组织学细胞密度也降低。当在同一类型的实验中使用MK801(一种非竞争性NMDA拮抗剂)时,也发现了类似的效果。两种实验方法的结果都使得NMDA拮抗剂很可能以某种方式干扰皮层可塑性。然而,它们的作用方式仍然不明确。虽然阻断NMDA通道很可能阻止了突触巩固所需的赫布相关性过程,但也可能必须考虑更复杂的效应,例如干扰通常通过NMDA受体发挥的神经营养作用。